RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Synthesis and anticonvulsant activity evaluation of 8-alkoxy-5-(4H-1,2,4-triazol-4-yl)quinoline derivatives

      한글로보기

      https://www.riss.kr/link?id=A104666258

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Two series of 8-alkoxy-5-(4H-1,2,4-triazol-4-yl)quinolines and 8-alkoxy-5-(2H-1,2,4-triazol-3-one-4-yl)quinolineswere synthesized.The anticonvulsant activity ofthese compounds was evaluated with maximal electroshockseizure test and rotarod test. Among the synthesized compounds,8-octoxy-5-(4H-1,2,4-triazol-4-yl)quinoline (4g)was the most active compound with ED50 of 8.80 mg/kg,TD50 of 176.03 mg/kg and protective index of 20.0. Itsneurotoxicity was lower than all other synthesized compoundsand also markedly lower than that of the referencedrug carbamazepine. In addition, the potency of compound 4gagainst seizures induced by pentylenetetrazole, 3-mercaptopropionicacid, and bicuculline suggested its broad spectrumactivity, and the mechanisms of action including inhibition ofvoltage-gated ion channels and modulation of GABAergicactivity might involve in its anticonvulsant activity.
      번역하기

      Two series of 8-alkoxy-5-(4H-1,2,4-triazol-4-yl)quinolines and 8-alkoxy-5-(2H-1,2,4-triazol-3-one-4-yl)quinolineswere synthesized.The anticonvulsant activity ofthese compounds was evaluated with maximal electroshockseizure test and rotarod test. Among...

      Two series of 8-alkoxy-5-(4H-1,2,4-triazol-4-yl)quinolines and 8-alkoxy-5-(2H-1,2,4-triazol-3-one-4-yl)quinolineswere synthesized.The anticonvulsant activity ofthese compounds was evaluated with maximal electroshockseizure test and rotarod test. Among the synthesized compounds,8-octoxy-5-(4H-1,2,4-triazol-4-yl)quinoline (4g)was the most active compound with ED50 of 8.80 mg/kg,TD50 of 176.03 mg/kg and protective index of 20.0. Itsneurotoxicity was lower than all other synthesized compoundsand also markedly lower than that of the referencedrug carbamazepine. In addition, the potency of compound 4gagainst seizures induced by pentylenetetrazole, 3-mercaptopropionicacid, and bicuculline suggested its broad spectrumactivity, and the mechanisms of action including inhibition ofvoltage-gated ion channels and modulation of GABAergicactivity might involve in its anticonvulsant activity.

      더보기

      참고문헌 (Reference)

      1 Hamilton, M. A., "Trimmed Spearman-Karber method for estimating median lethal concentration in toxicity bioassays" 7 : 714-719, 1977

      2 Blanch, L. B., "Topological virtual screening : A way to find new anticonvulsant drugs from chemical diversity" 13 : 2749-2754, 2003

      3 Okada, R., "The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures" 480 : 383-387, 1989

      4 Lo¨scher, W., "The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices" 9 : 1-10, 1991

      5 Alam, O., "Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives" 45 : 2467-2472, 2010

      6 Karakurt, A., "Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives" 18 : 2902-2911, 2010

      7 Krall, R. J., "Synthesis of 8-alkoxy-4, 5-dihydro-[1, 2, 4]triazole[4, 3-a]quinoline-1-ones and evaluation of their anticonvulsant properties" 19 : 409-, 1978

      8 Xian-Yu Sun, "Synthesis of 8-Alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and Evaluation of their Anticonvulsant Properties" 대한약학회 29 (29): 1080-1085, 2006

      9 Wei, C. X., "Synthesis of 2-substituted-7-heptyloxy-4, 5-dihydro-[1, 2, 4]-triazolo[ 4, 3-a]quinolin-1(2H)-ones with anticonvulsant activity" 340 : 491-495, 2007

      10 Cui, X. S., "Synthesis and anticonvulsant evaluation of 3-substituted-4-(4-hexyloxyphenyl)-4H-1, 2, 4-triazoles" 18 : 49-58, 2009

      1 Hamilton, M. A., "Trimmed Spearman-Karber method for estimating median lethal concentration in toxicity bioassays" 7 : 714-719, 1977

      2 Blanch, L. B., "Topological virtual screening : A way to find new anticonvulsant drugs from chemical diversity" 13 : 2749-2754, 2003

      3 Okada, R., "The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures" 480 : 383-387, 1989

      4 Lo¨scher, W., "The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices" 9 : 1-10, 1991

      5 Alam, O., "Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives" 45 : 2467-2472, 2010

      6 Karakurt, A., "Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives" 18 : 2902-2911, 2010

      7 Krall, R. J., "Synthesis of 8-alkoxy-4, 5-dihydro-[1, 2, 4]triazole[4, 3-a]quinoline-1-ones and evaluation of their anticonvulsant properties" 19 : 409-, 1978

      8 Xian-Yu Sun, "Synthesis of 8-Alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and Evaluation of their Anticonvulsant Properties" 대한약학회 29 (29): 1080-1085, 2006

      9 Wei, C. X., "Synthesis of 2-substituted-7-heptyloxy-4, 5-dihydro-[1, 2, 4]-triazolo[ 4, 3-a]quinolin-1(2H)-ones with anticonvulsant activity" 340 : 491-495, 2007

      10 Cui, X. S., "Synthesis and anticonvulsant evaluation of 3-substituted-4-(4-hexyloxyphenyl)-4H-1, 2, 4-triazoles" 18 : 49-58, 2009

      11 Arnoldi, A., "Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2, 3-dihydro-4H-1-ben-zopyrans and-benzothiopyrans" 33 : 2865-2869, 1990

      12 Jin, Y. Z., "Synthesis and anticonvulsant activity study of 7-substituted phenoxyl-4, 5-dihydro[1, 2, 4]triazolo[4, 3-a]quinolines and quinoline-1(2H)-ones" 27 : 1567-1572, 2007

      13 Zhang, L. Q., "Synthesis and anticonvulsant activity of some 7-alkoxy-2H-1, 4-benzothiazin-3(4H)-ones and 7-alkoxy-4H-[1, 2, 4]triazolo [4, 3-d]benzo[b][1, 4]thiazines" 58 : 326-331, 2010

      14 Deng, X. Q., "Synthesis and anticonvulsant activity of 7-phenyl-6, 7-dihydro-[1, 2, 4]triazolo[1, 5-a]pyrimidin-5(4H)-ones and their derivatives" 46 : 2955-2963, 2010

      15 Xie, Z. F., "Synthesis and anticonvulsant activity of 7-alkoxyl-4, 5-dihydro-[1, 2, 4]triazolo[4, 3-a] quinolines" 15 : 4803-4805, 2005

      16 Deng, X. Q., "Synthesis and anticonvulsant activity of 7-alkoxy-triazolo-[3, 4-b]benzo[d]thiazoles" 6 : 313-320, 2010

      17 Zhang, L., "Synthesis and anticonvulsant activity of 6-alkoxy-[1, 2, 4]triazolo[3, 4-a]phthalazines" 73 : 313-319, 2009

      18 Song, M. X., "Synthesis and anticonvulsant activity evaluation of 6-phenyl-7H-[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazines" 8 : 769-775, 2010

      19 Macdonald, R. L., "Specific antagonism of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons : a common mode of convulsant action" 28 : 325-330, 1978

      20 Yi, L., "Six-and four-coordinated zinc(II)complexes exhibit strong blue fluorescent properties" 6 : 1209-1212, 2003

      21 Brown, T. R., "Primary care : Epilepsy" 344 : 1145-1151, 2001

      22 Stefan, H., "Novel anticonvulsant drugs" 113 : 165-183, 2007

      23 Donner, E. J., "New generation anticonvulsants for the treatment of epilepsy in children" 3 : 170-180, 2006

      24 Yogeeswari, P., "Neuropathic pain : Strategies in drug discovery and treatment" 2 : 169-184, 2007

      25 Estrada, E., "In silico studies for the rational discovery of anticonvulsant compounds" 8 : 2755-2770, 2000

      26 Prasad, A. N., "Genetic influences on the risk of epilepsy. In Pediatric epilepsy: Diagnosis and therapy, 3rd ed" Demos Publishers 2001

      27 Bernasconi, R., "Gamma-vinyl GABA : Comparison of neurochemical and anticonvulsant effects in mice" 72 : 213-233, 1988

      28 Olsen, R. W, "GABA-benzodiazepine-barbiturate receptor interactions" 37 : 1-13, 1981

      29 Gale, K., "GABA and epilepsy, basic concepts from preclinical research" 33 : 3-12, 1992

      30 Shao, N., "Efficient one-pot formation of 4-N-substituted 2, 4-dihydro-3H-1, 2, 4-triazolin-3-ones from primary amines using N0-(ethoxymethylene)hydrazinecarboxylic acid methyl ester" 47 : 6743-6746, 2006

      31 Lo¨scher, W., "Effects of the non-NMDA antagonists NBQX and the 2, 3-benzodiazepine GYKI 52466 on different seizure types in mice : Comparison with diazepam and interactions with flumazenil" 2 : 145-181, 1988

      32 McNamara, J. O., "Drugs effective in the therapy of the epilepsies. In Goodman and Gilman’s the pharmacological basis of therapeutics" McGraw-Hill 521-547, 2001

      33 Perucca, E., "Development of new antiepileptic drugs : Challenges, incentives, and recent advance" 6 : 793-804, 2007

      34 Guo, L. J., "Design and synthesis of 5-alkoxy-[1, 2, 4]triazolo[4, 3-a]quinoline derivatives with anticonvulsant activity" 44 : 954-958, 2009

      35 Deng, X.Q., "Design and synthesis of 10-alkoxy-5,6-dihydro-triazolo [4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity" 45 : 3080-3086, 2010

      36 Pollard, J. R., "Antiepileptic drugs in development" 5 : 1064-1067, 2006

      37 Poter, R. J., "Antiepileptic drug development program" 51 : 293-, 1984

      38 Jin, H. G., "Anticonvulsant and toxicity evaluation of some 7-alkoxy-4, 5-dihydro-[1, 2, 4]triazolo[4, 3-a]quinoline-1(2H)-ones" 14 : 6868-6873, 2006

      39 Hester Jr., J.B., "6-Aryl-4H-s-triazolo[4, 3-a][1, 4]benzodiazepines. Influence of 1-substitution on pharmacological activity" 22 : 1390-1398, 1979

      40 Lo¨scher, W, "3-Mercaptopropionic acid : convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine" 28 : 1397-1407, 1979

      41 Hester Jr., J.B., "2, 4-Dihydro-6-phenyl-(1H)-triazolo [4, 3-a][1, 4]benzodiazepine-1-ones with antianxiety and antidepressant activity" 23 : 402-405, 1980

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.96 0.2 1.44
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.07 0.87 0.439 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼